Search clinical trials for: C-CAR088

Total 3680 results

Peking Union Medical College Hospital
Cellular Biomedicine Group Ltd.

Unknown

A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Multiple Myeloma

China
Institute of Hematology & Blood Diseases Hospital

Unknown

A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Multiple Myeloma

China
Institute of Hematology & Blood Diseases Hospital
Cellular Biomedicine Group Ltd.

Recruiting

ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)

Multiple Myeloma

China
Hebei Yanda Ludaopei Hospital

Unknown

A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
The First Affiliated Hospital with Nanjing Medical...

Unknown

A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
Peking University People's Hospital
Cellular Biomedicine Group Ltd.

Unknown

C-CAR011 Treatment in Subjects With ALL After HSCT

Acute Lymphoblastic Leukemia(ALL)

China
Institute of Hematology & Blood Diseases Hospital
Cellular Biomedicine Group Ltd.

Completed

A Study of C-CAR066 in Subjects With r/r Diffuse Large B Cell Lymphoma Who Received CD19 CAR-T Therapy

Diffuse Large B Cell Lymphoma

China
First Affiliated Hospital of Zhejiang University
Cellular Biomedicine Group Ltd.

Active, not recruiting

A Study of C-CAR039 Treatment in Subjects With r/r NHL Subjects Non-Hodgkin's Lymphoma

Non-Hodgkin's B-cell Lymphoma

China
Tianjin Medical University Cancer Institute and...
Cellular Biomedicine Group Ltd.

Active, not recruiting

A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma

Non-Hodgkin's B-cell Lymphoma

China
Cellular Biomedicine Group Ltd.

Recruiting

A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma (ELEVATION)

Relapsed/Refractory Large B-Cell Lymphoma

China
Janssen Research & Development, LLC
Mayo Clinic

Recruiting

A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

United States, Australia
Shanghai Tongji Hospital, Tongji University School...
Cellular Biomedicine Group Ltd.

Active, not recruiting

A Study Evaluating Safety and Efficacy of C-CAR039 Treatment in NHL Subjects

Non-Hodgkin's B-cell Lymphoma

China
Shanghai Tongji Hospital, Tongji University School...
Cellular Biomedicine Group Ltd.

Completed

A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy

B Cell Lymphoma

China
RenJi Hospital
AbelZeta Pharma Inc.

Recruiting

A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy (CAR-AID)

Systemic Lupus Erythematosus (SLE) | Neuromyelitis Optica Spectrum Disorders | Immune-Mediated Necrotizing Myopathy | Multiple Sclerosis-Relapsing-Remitting

China
Cellular Biomedicine Group Ltd.
Shanghai Tongji Hospital, Tongji University School of Medicine

Unknown

Study of Safety and Efficacy of C-CAR011 in B-NHL Patients

Refractory or Relapsed Non-Hodgkin Lymphoma

China
Cellular Biomedicine Group Ltd.
Tianjin Medical University Cancer Institute and Hospital

Unknown

A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma

China
Peking University
Peking University Cancer Hospital & Institute

Recruiting

A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma

B Cell Non-Hodgkin's Lymphoma

China
Peking Union Medical College Hospital
Cellular Biomedicine Group Ltd.

Completed

A PhaseⅠb Study Evaluating Safety and Efficacy of C-CAR011 Treatment in B- NHL Subjects

B-cell Non-Hodgkin Lymphoma

China
Cortexyme Inc.

Completed

A Multiple Ascending Dose Study of COR388

Alzheimer Disease

United States
Cortexyme Inc.

Completed

A Single and Multiple Ascending Dose Study of COR588

Healthy Volunteers

Australia
CANbridge Life Sciences Ltd.

Unknown

To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM)

GBM
Cortexyme Inc.

Completed

Study of COR388 HCl in Healthy Subjects

Healthy Subjects

United States
CANbridge Life Sciences Ltd.

Recruiting

Phase 2 Study of CAN008 in Subjects With GBM

Newly-diagnosed Glioblastoma

China
Cortexyme Inc.

Completed

GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease

Alzheimer Disease

United States, Spain, Poland, United Kingdom, France, Netherlands
CANbridge Life Sciences Ltd.

Completed

A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme

Glioblastoma Multiforme

Taiwan
IlDong Pharmaceutical Co Ltd

Completed

A Drug Interaction Study of Cilnidipine and Valsartan

Healthy

Korea, Republic of
International Centre for Diarrhoeal Disease Research...
University of California, Davis

Completed

Community-based Follow-up of Severely Malnourished Children

Malnourished Children
Arbor Pharmaceuticals, Inc.

Terminated

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

Vasomotor Symptoms (VMS)

United States
Zhejiang University

Recruiting

A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
University of Miami

Recruiting

The CHILD Trial: Hypoplastic Left Heart Syndrome Study. (CHILD)

Hypoplastic Left Heart Syndrome

United States
Eli Lilly and Company

Completed

A Study of [¹⁴C]-LY3484356 in Healthy Female Participants

Healthy

United States
Eli Lilly and Company

Completed

A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer

Advanced Cancer

United Kingdom
Direction Centrale du Service de Santé des Armées

Recruiting

Assessment of the Effects of a 24-hour Cold and Heat Exposure on the Factors Influencing Food Intake (TEMPCA)

Eating Habit | Cold Exposure | Heat

France
Kolon Life Science

Completed

Safety and Biological Efficacy Study of TisssueGene-C to Degenerative Arthritis

Degenerative Arthritis

Korea, Republic of
Massachusetts General Hospital
National Center for Complementary and Integrative Health (NCCIH)

Active, not recruiting

Live Video Mind-body Treatment to Prevent Persistent Symptoms Following mTBI

Anxiety | MTBI - Mild Traumatic Brain Injury

United States
Otto Bock Healthcare Products GmbH

Completed

C-Leg 3 and C-Leg 4 Study in Transfemoral Amputees

Lower Limb Amputation Above Knee (Injury)

Austria, Belgium
Assiut University

Unknown

C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia
University of Massachusetts, Worcester
National Institute of Nursing Research (NINR)

Completed

Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults (LEAP-C)

Hepatitis c

United States
U.S. Army Medical Research and Development Command
PPD; Idorsia Pharmaceuticals Ltd.; Berry Consultants; Cambridge Cognition Ltd; Ci...

Recruiting

Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant

Post Traumatic Stress Disorder

United States
UNC Lineberger Comprehensive Cancer Center

Recruiting

Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma

Immune System Diseases | Multiple Myeloma

United States
Alaunos Therapeutics

Unknown

Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas

Advanced Solid Tumors | Lymphomas

Canada
The University of Texas at Dallas
National Institute on Aging (NIA); University of Texas Southwestern Medical...

Completed

Strategic Training to Optimize Neurocognitive Functions in Older Adults (ViCTOR)

Functional Magnetic Resonance Imaging | Cognitive Aging

United States
University of East Anglia
The Stroke Association, United Kingdom; Norwich Clinical Trials Unit, UK

Recruiting

Can we Use c-SIGHT for Spatial Neglect in Stroke Survivors' Homes? (c-SIGHT)

Stroke | Spatial Neglect | Inattention

United Kingdom
AstraZeneca

Completed

Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease

Crohn's Disease

Japan
Medical University of Warsaw

Completed

Endotracheal Intubation in Prehospital Scenario

Endotracheal Intubation

Poland
Alaunos Therapeutics

Unknown

Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas

Advanced Cancer

United States
ARCIM Institute Academic Research in Complementary...
Universität Tübingen

Completed

Temperature-dependent Changes in Cardiovascular Parameters During Warm Water Footbaths in Healthy Women

Cardiovascular System | Autonomic Nervous System | Warm Footbath

Germany
Kolon TissueGene, Inc.

Not yet recruiting

Study to Determine the Safety and Tolerability of TG-C in Subjects With Back Pain Due to Degenerative Disc Disease

Degenerative Disc Disease
Kolon TissueGene, Inc.

Recruiting

A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee

Degenerative Osteoarthritis

United States
Mayo Clinic

Enrolling by invitation

Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders (AND1)

Parkinson Disease | Semantic Dementia | Behavioral Variant of Frontotemporal Dementia | CBD | Apraxia of Speech | MSA - Multiple System Atrophy | FTD | PPA | PSP | PCA | LPA | Semantic Aphasia

United States

Search clinical trials for: C-CAR088

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations